Literature DB >> 11880521

Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates.

Lu Pu1, Guo-Bin Bao, Nan-Jie Xu, Lan Ma, Gang Pei.   

Abstract

Chronic exposure to opiates eventually leads to drug addiction, which is believed to involve maladaptive changes in brain function, but the underlying neuronal mechanisms remain primarily unknown. Given the known effects of opiates such as morphine and heroin on hippocampal function, we investigated the potential effect of chronic opiate treatment on long-term potentiation (LTP) at CA1 synapses in rat hippocampus, a leading experimental model for studying synaptic plasticity. Our results revealed that chronic exposure of rats to morphine or heroin, which induced severe drug tolerance and dependence, markedly reduced the capacity of hippocampal CA1 LTP during the period of drug withdrawal (from approximately 190% in control to approximately 120%). More interestingly, the capacity of LTP could be restored to the normal level by re-exposure of the animals to opiates, indicating that the synaptic function was already adapted to opiates. Morris water maze test, which measures behavioral consequences of synaptic plasticity, showed parallel learning deficits after chronic exposure to opiates. Moreover, the opiate-reduced LTP could also be restored by inhibitors of cAMP-dependent protein kinase A (PKA), suggesting that upregulation of cAMP pathway was likely one of the underlying mechanisms of the observed phenomena. These findings demonstrated that chronic opiate treatment can significantly modulate synaptic plasticity in the hippocampus, leading to an opiate dependence of the plasticity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880521      PMCID: PMC6758897     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

Review 1.  Long-term potentiation--a decade of progress?

Authors:  R C Malenka; R A Nicoll
Journal:  Science       Date:  1999-09-17       Impact factor: 47.728

2.  Immunoprecipitation of high-affinity, guanine nucleotide-sensitive, solubilized mu-opioid receptors from rat brain: coimmunoprecipitation of the G proteins G(alpha o), G(alpha i1), and G(alpha i3).

Authors:  E Chalecka-Franaszek; H B Weems; A T Crowder; B M Cox; T E Côté
Journal:  J Neurochem       Date:  2000-03       Impact factor: 5.372

3.  Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice.

Authors:  A J Silva; C F Stevens; S Tonegawa; Y Wang
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

4.  Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801.

Authors:  K A Trujillo; H Akil
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

5.  Increased probability of GABA release during withdrawal from morphine.

Authors:  A Bonci; J T Williams
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

Review 6.  A synaptic model of memory: long-term potentiation in the hippocampus.

Authors:  T V Bliss; G L Collingridge
Journal:  Nature       Date:  1993-01-07       Impact factor: 49.962

7.  Opiates inhibit neurogenesis in the adult rat hippocampus.

Authors:  A J Eisch; M Barrot; C A Schad; D W Self; E J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

8.  Modulation of protein kinase C and cAMP-dependent protein kinase by delta-opioid.

Authors:  L G Lou; G Pei
Journal:  Biochem Biophys Res Commun       Date:  1997-07-30       Impact factor: 3.575

9.  A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function.

Authors:  R Z Terwilliger; D Beitner-Johnson; K A Sevarino; S M Crain; E J Nestler
Journal:  Brain Res       Date:  1991-05-10       Impact factor: 3.252

10.  Drug addiction: bad habits add up.

Authors:  T W Robbins; B J Everitt
Journal:  Nature       Date:  1999-04-15       Impact factor: 49.962

View more
  55 in total

1.  Hippocampal GluA1-containing AMPA receptors mediate context-dependent sensitization to morphine.

Authors:  Yan Xia; George S Portugal; Amanda K Fakira; Zara Melyan; Rachael Neve; H Thomas Lee; Scott J Russo; Jie Liu; Jose A Morón
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  Delta opioid receptors colocalize with corticotropin releasing factor in hippocampal interneurons.

Authors:  T J Williams; T A Milner
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

3.  Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization.

Authors:  Shoshana Eitan; Camron D Bryant; Nazli Saliminejad; Yu C Yang; Elroy Vojdani; Duane Keith; Roberto Polakiewicz; Christopher J Evans
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

4.  Extracellular matrix plasticity and GABAergic inhibition of prefrontal cortex pyramidal cells facilitates relapse to heroin seeking.

Authors:  Michel C Van den Oever; Bart R Lubbers; Natalia A Goriounova; Ka W Li; Roel C Van der Schors; Maarten Loos; Danai Riga; Joost Wiskerke; Rob Binnekade; M Stegeman; Anton N M Schoffelmeer; Huibert D Mansvelder; August B Smit; Taco J De Vries; Sabine Spijker
Journal:  Neuropsychopharmacology       Date:  2010-06-30       Impact factor: 7.853

Review 5.  Some recent advances in basic neuroscience research in China.

Authors:  Mu-ming Poo; Aike Guo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

Review 6.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Extinction of morphine-dependent conditioned behavior is associated with increased phosphorylation of the GluR1 subunit of AMPA receptors at hippocampal synapses.

Authors:  Sophie K Billa; Namita Sinha; Sri Rajyalakshmi Rudrabhatla; Jose A Morón
Journal:  Eur J Neurosci       Date:  2008-12-11       Impact factor: 3.386

8.  Neonatal morphine administration leads to changes in hippocampal BDNF levels and antioxidant enzyme activity in the adult life of rats.

Authors:  J R Rozisky; G Laste; I C de Macedo; V S Santos; R Krolow; C Noschang; C Vanzella; K Bertoldi; G A Lovatel; I C C de Souza; I R Siqueira; C Dalmaz; W Caumo; I L S Torres
Journal:  Neurochem Res       Date:  2012-12-09       Impact factor: 3.996

9.  Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation.

Authors:  José A Morón; Srinivas Gullapalli; Chirisse Taylor; Achla Gupta; Ivone Gomes; Lakshmi A Devi
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

10.  Shotgun proteomics in neuroscience.

Authors:  Lujian Liao; Daniel B McClatchy; John R Yates
Journal:  Neuron       Date:  2009-07-16       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.